Common use of Sample Collection Clause in Contracts

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division prior to the beginning of a specific watch to test entry-level probationary officers. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officers. When a test subject is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer is tested upon the employee's return to the work site. Only the highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division be assigned to the collection process. The division/Area supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's License, etc.) by each subject. An MLS employee of the same sex as the subject will accompany the subject to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's corresponding confidential test number. The subject will be directed/ordered to provide a urine sample. The sample collection shall be monitored by the MLS employee in an atmosphere of privacy and dignity. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve all overtime worked due to urine sample collection. All test subjects will be admonished that disciplinary action will be taken if a test subject attempts to dilute or, in any way, tamper with a urine sample. In the presence of the MLS employee, the subject will be required to place and secure a lid on the urine sample container. The subject's right thumb print will then be inked and rolled on a specially prepared gummed label by the MLS employee who monitored the test. The subject will then affix the label to the urine sample container. The container will then display the subject's confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container and lid in the presence of the test subject. This process will ensure a tamper-proof sample. In order to preserve the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for the transportation of the sample(s) and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Property Division. The sample(s) will be delivered to SID by MLS personnel. The confidential test identification number of each test subject will be used instead of the employee's name on Department documents to ensure confidentiality.

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division prior to the beginning of a specific watch to test entry-level probationary officersemployees. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. The DTU will test whoever is on the list, probationer or tenured employee. The Drug Test Officer maintains possession of the Department Drug Monitoring Log, and provides the names of the employees subject to testing to the Watch Commander or Officer-In-Charge. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officersemployees. When a test subject an employee is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer employee is tested upon the employee's return to the work sitesite as long as the employee’s name remains on the current list. Only the The highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division be assigned to the collection process. The division/Area supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject employee identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's License, etc.) by each subjectemployee. An MLS employee of the same sex as the subject employee being tested will accompany the subject employee to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject employee with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's employee’s corresponding confidential test number. The subject employee will be directed/ordered to provide a urine sample. The sample collection shall be monitored by the MLS employee in an atmosphere of privacy and dignity. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects Employees will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects Employees who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve substantiate all overtime worked due to urine sample collection, which must be approved by a supervisor. All test subjects tested employees will be admonished that disciplinary action will be taken if a test subject an employee attempts to dilute or, in any way, tamper with a urine sample. The provided sample will be divided between two sample containers, each labeled with the tested employee’s corresponding confidential test number. The sample will be divided by the tested employee in the presence of the MLS employee. In the presence of the MLS employee, the subject employee will be required to place and secure a lid on the each urine sample container. The subject's employee’s right thumb print will then be inked and rolled on a two specially prepared gummed label labels by the MLS employee who monitored the test. The subject tested employee will then affix the label labels to the each urine sample container. The container containers will then display the subject's employee’s confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container containers and lid in the presence of the test subjecttested employee. This process will ensure a tamper-proof sample. In order to preserve the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for transporting the transportation of the sample(s) samples and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Property Division. The sample(s) On a weekly basis, the samples will be delivered to SID FSD by MLS personnel, along with a copy of the FSD Confidential Drug Sample Report. The confidential test identification number of each test subject tested employee will be used instead of the employee's name on Department documents to ensure confidentiality. Medical Liaison Section will maintain the second sample in a secure environment in Property Division until notified by the investigator that the sample may be disposed of. If long-term storage is required for positive samples, they will be booked into Property Division by the investigator.

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division Division prior to the beginning of a specific watch to test entry-level probationary officersemployees. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. The DTU will test whoever is on the list, probationer or tenured employee. The Drug Test Officer maintains possession of the Department Drug Monitoring Log, and provides the names of the employees subject to testing to the Watch Commander or Officer-In-Charge. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officersemployees. When a test subject an employee is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer employee is tested upon the employee's ’s return to the work sitesite as long as the employee’s name remains on the current list. Only the The highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division Division be assigned to the collection process. The divisionArea/Area Division supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject employee identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's ’s License, etc.) by each subjectemployee. An MLS employee of the same sex as gender with which the subject employee being tested identifies will accompany the subject employee to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject employee with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's employee’s corresponding confidential test number. The subject employee will be directed/ordered to provide a urine sample. The sample collection shall be monitored by the MLS employee in an atmosphere of privacy and dignity. The parties agree to continue to meet and confer on affording unit members the opportunity to select an MLS employee who is the same gender as the MLS employee identifies. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects Employees will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects Employees who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve substantiate all overtime worked due to urine sample collection, which must be preapproved by an Area/Division supervisor. All test subjects tested employees will be admonished that disciplinary action will be taken if a test subject an employee attempts to dilute or, in any way, tamper with a urine sample. The provided sample will be divided between two sample containers, each labeled with the tested employee’s corresponding confidential test number. The sample will be divided by the tested employee in the presence of the MLS employee. In the presence of the MLS employee, the subject employee will be required to place and secure a lid on the each urine sample container. The subject's employee’s right thumb print will then be inked and rolled on a two specially prepared gummed label labels by the MLS employee who monitored the test. The subject tested employee will then affix the label labels to the each urine sample container. The container containers will then display the subject's employee’s confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container containers and lid in the presence of the test subjecttested employee. This process will ensure a tamper-proof sample. In order to preserve the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for transporting the transportation of the sample(s) samples and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Evidence Property Management Division. The sample(s) On a weekly basis, the samples will be delivered to SID FSD by MLS personnel, along with a copy of the FSD Confidential Drug Sample Report. The confidential test identification number of each test subject tested employee will be used instead of the employee's name on Department documents to ensure confidentiality. Medical Liaison Section will maintain the second sample in a secure environment in Property Division until notified by the investigator that the sample may be disposed of. If long-term storage is required for positive samples, they will be booked into Evidence Property Management Division by the investigator.

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division prior to the beginning of a specific watch to test entry-level probationary officersemployees. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. The DTU will test whoever is on the list, probationer or tenured employee. The Drug Test Officer maintains possession of the Department Drug Monitoring Log, and provides the names of the employees subject to testing to the Watch Commander of Officer-In-Charge. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officersemployees. When a test subject an employee is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer employee is tested upon the employee's return to the work sitesite as long as the employee’s name remains on the current list. Only the The highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division be assigned to the collection process. The division/Area supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject employee identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's License, etc.) by each subjectemployee. An MLS employee of the same sex as the subject employee being tested will accompany the subject employee to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject employee with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's employee’s corresponding confidential test number. The subject employee will be directed/ordered to provide a urine sample. The sample collection shall be monitored by the MLS employee in an atmosphere of privacy and dignity. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects Employees will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects Employees who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve substantiate all overtime worked due to urine sample collection, which must be approved by a supervisor. All test subjects tested employees will be admonished that disciplinary action will be taken if a test subject an employee attempts to dilute or, in any way, tamper with a urine sample. The provided sample will be divided between two sample containers, each labeled with the tested employee’s corresponding confidential test number. The sample will be divided by the tested employee in the presence of the MLS employee. In the presence of the MLS employee, the subject employee will be required to place and secure a lid on the each urine sample container. The subject's employee’s right thumb print will then be inked and rolled on a two specially prepared gummed label labels by the MLS employee who monitored the test. The subject tested employee will then affix the label labels to the each urine sample container. The container containers will then display the subject's employee’s confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container containers and lid in the presence of the test subjecttested employee. This process will ensure a tamper-proof sample. In order to preserve the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for transporting the transportation of the sample(s) samples and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Property Division. The sample(s) On a weekly basis, the samples will be delivered to SID by MLS personnel, along with a copy of the SID Confidential Drug Sample Report. The confidential test identification number of each test subject tested employee will be used instead of the employee's name on Department documents to ensure confidentiality. Medical Liaison Section will maintain the second sample in a secure environment in Property Division until notified by the investigator that the sample may be disposed of. If long-term storage is required for positive samples, they will be booked into Property Division by the investigator.

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division prior to the beginning of a specific watch to test entry-level probationary officers. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officers. When a test subject is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer is tested upon the employee's return to the work site. Only the highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division be assigned to the collection process. The division/Area supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's License, etc.) by each subject. An MLS employee of the same sex as the subject will accompany the subject to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's corresponding confidential test number. The subject A Police Officer Drug Testing Examination Form will be directed/ordered issued to provide a urine sample. The sample collection shall be monitored by the MLS employee each subject in an atmosphere of privacy and dignity. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve all overtime worked due to urine sample collection. All test subjects will be admonished that disciplinary action will be taken if a test subject attempts to dilute or, in any way, tamper with a urine sample. In the presence of the MLS employee, the subject will be required to place and secure a lid on the urine sample container. The subject's right thumb print will then be inked and rolled on a specially prepared gummed label by the MLS employee who monitored the test. The subject will then affix the label to the urine sample container. The container will then display the subject's confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container and lid in the presence of the test subject. This process will ensure a tamper-proof sample. In order to preserve determine the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for the transportation of the sample(s) and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Property Division. The sample(s) will be delivered to SID by MLS personnel. The confidential test identification number of each test subject will be used instead of the employee's name on Department documents to ensure confidentiality.following:

Sample Collection. Medical Liaison Section sworn personnel will be responsible for the actual urine collection process. When directed by the Drug Testing Coordinator, they will report to Training Division or an Area/division prior to the beginning of a specific watch to test entry-level probationary officersemployees. They will have a copy of a Department Drug Monitoring Log which will list the names and corresponding serial numbers and confidential test numbers of those officers to be tested that day. The DTU will test whoever is on the list, probationer or tenured employee. The Drug Test Officer maintains possession of the Department Drug Monitoring Log, and provides the names of the employees subject to testing to the Watch Commander or Officer-In-Charge. At the test location, MLS personnel shall inform the Commanding Officer, or the highest ranking officer present, of the reason for their presence. They will provide a confidential list of those officers to be tested. A determination will be made as to the availability of the officersemployees. When a test subject an employee is not working (regular day off, vacation, etc.) or is unavailable (court attendance, booking of a suspect, etc.), MLS personnel will ensure that the officer employee is tested upon the employee's return to the work sitesite as long as the employee’s name remains on the current list. Only the The highest ranking officer available will be aware of the name(s) of the officer(s) to be tested upon return to the station. The MLS employee will request that an officer of the rank of Sergeant I or Detective II or higher from the Area/division be assigned to the collection process. The division/Area supervisor will be responsible for notifying the available officers of the test and assuring that they immediately report to the MLS employee for processing. Verification of test subject employee identification will be made through the presentation of appropriate identification (Los Angeles Police Identification Card, California Driver's License, etc.) by each subjectemployee. An MLS employee of the same sex as the subject employee being tested will accompany the subject employee to a Department restroom facility. Once inside the restroom facility, the MLS employee will provide the test subject employee with a Department-approved urine sample container. The container will have affixed to it a label which reflects the test subject's employee’s corresponding confidential test number. The subject employee will be directed/ordered to provide a urine sample. The sample collection shall be monitored by the MLS employee in an atmosphere of privacy and dignity. Note: Refusal to obey the order may result in disciplinary action for insubordination up to and including termination. Additionally, the Department will reserve the right to require that a urine test be administered when the employee exhibits objective symptoms of being under the influence of alcohol and/or a narcotic or drug or when there is a reasonable and articulated suspicion that the employee has ingested or absorbed in any other manner an alcoholic beverage, narcotic or drug. Test subjects Employees will be required to provide at least 50 cubic centimeters of urine for testing purposes. Subjects Employees who are initially unable to provide a sufficient quantity of urine will be required to remain under the supervision of the MLS employee until a sufficient quantity can be deposited. The MLS employee shall approve substantiate all overtime worked due to urine sample collection, which must be approved by a supervisor. All test subjects tested employees will be admonished that disciplinary action will be taken if a test subject an employee attempts to dilute or, in any way, tamper with a urine sample. The provided sample will be divided between two sample containers, each labeled with the tested employee’s corresponding confidential test number. The sample will be divided by the tested employee in the presence of the MLS employee. In the presence of the MLS employee, the subject employee will be required to place and secure a lid on the each urine sample container. The subject's employee’s right thumb print will then be inked and rolled on a two specially prepared gummed label labels by the MLS employee who monitored the test. The subject tested employee will then affix the label labels to the each urine sample container. The container containers will then display the subject's employee’s confidential test identification number and right thumb print for future identification purposes. Additionally, the MLS employee will sign and date two evidence seals and affix them to the container containers and lid in the presence of the test subjecttested employee. This process will ensure a tamper-proof sample. In order to preserve the chain or continuity of evidence, the MLS employee monitoring the collection sample will be responsible for transporting the transportation of the sample(s) samples and a copy of the Scientific Investigation Division Confidential Drug Sample Report to SID for processing. During other than normal business hours, the MLS employee responsible for the sample(s) will store them in a secure environment in Property Division. The sample(s) On a weekly basis, the samples will be delivered to SID by MLS personnel, along with a copy of the SID Confidential Drug Sample Report. The confidential test identification number of each test subject tested employee will be used instead of the employee's name on Department documents to ensure confidentiality. Medical Liaison Section will maintain the second sample in a secure environment in Property Division until notified by the investigator that the sample may be disposed of. If long-term storage is required for positive samples, they will be booked into Property Division by the investigator.